ACE Inhibitors: The Heart of Hypertension Treatment | Community Health

ACE inhibitors, introduced in the 1980s, have revolutionized the treatment of hypertension and heart failure. These drugs, such as lisinopril and enalapril, work by blocking the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor. With over 40 million prescriptions annually in the US alone, ACE inhibitors have become a cornerstone of cardiovascular therapy. However, their use is not without controversy, with debates surrounding their efficacy in certain patient populations and potential side effects, such as cough and kidney damage. As research continues to uncover the complexities of the renin-angiotensin-aldosterone system, the future of ACE inhibitors remains uncertain. With the rise of alternative therapies, such as ARBs and direct renin inhibitors, the role of ACE inhibitors in modern medicine is being reevaluated. The Vibe score for ACE inhibitors is 82, reflecting their significant cultural and medical impact.